Suchergebnisse - "Castagnetti, F"

PubPharm (7)

1

Hyper-activation of Aurora kinase a-polo-like kinase 1-FOXM1 axis promotes chronic myeloid leukemia resistance to tyrosine kinase inhibitors

enthalten in: Journal of experimental & clinical cancer research : CR | 2019

von Mancini, M. | De Santis, S. | Monaldi, C. | +9

2

Prognosis of long-term survival considering disease-specific death in patients with chronic myeloid leukemia

enthalten in: Leukemia | 2016

von Pfirrmann, M. | Baccarani, M. | Saussele, S. | +8

3

Managing chronic myeloid leukaemia in the elderly with intermittent imatinib treatment

enthalten in: Blood cancer journal | 2015

von Russo, D. | Malagola, M. | Skert, C. | +34

4

Long-term outcome of chronic myeloid leukemia patients treated frontline with imatinib

enthalten in: Leukemia | 2015

von Castagnetti, F. | Gugliotta, G. | Breccia, M. | +123

5

The EUTOS prognostic score : review and validation in 1288 patients with CML treated frontline with imatinib

enthalten in: Leukemia | 2013

von Hoffmann, V. | Baccarani, M. | Lindoerfer, D. | +11

6

Investigating factors associated with adherence behaviour in patients with chronic myeloid leukemia : an observational patient-centered outcome study

enthalten in: British journal of cancer | 2012

von Efficace, F. | Baccarani, M. | Rosti, G. | +12

CommentIn: Br J Cancer. 2012 Sep 4;107(6):901-3. - PMID 22951951

7

Prediction of response to imatinib by prospective quantitation of BCR-ABL transcript in late chronic phase chronic myeloid leukemia patients

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2006

von Martinelli, G. | Iacobucci, I. | Rosti, G. | +12

1
[1]